Rhenman & Partners Asset Management AB »

United Therapeutics Corporation shares owned by Rhenman & Partners Asset Management AB

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Rhenman & Partners Asset Management AB from 13F filings

Historical chart of Rhenman & Partners Asset Management AB investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Rhenman & Partners Asset Management AB

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.4M 8.0k 419.21

More positions owned by Rhenman & Partners Asset Management AB

Boston Scientific Corporation (BSX)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Danaher Corporation (DHR)
Alignment Healthcare (ALHC)
Intuitive Surgical Com New (ISRG)
UnitedHealth (UNH)
Axsome Therapeutics (AXSM)
CVS Caremark Corporation (CVS)
McKesson Corporation (MCK)
Regeneron Pharmaceuticals (REGN)
Ionis Pharmaceuticals (IONS)
Medtronic SHS (MDT)
AmerisourceBergen (COR)
EXACT Sciences Corporation (EXAS)

View all positions for Rhenman & Partners Asset Management AB

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Invesco
Assetmark
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation